Riskpilot← Back to searchSign inGet full accessFOKUS KLINIKK AS
ASActiveOrg 914010969Tørkoppveien 6, 1570 DillingOther human health activities n.e.c. · NACE 8699Est. 20140 employees
Revenue 2024
NOK 2M
+4% vs 2023
EBITDA margin
7.7%
-30% vs 2023
Equity ratio
57.4%
Financial strength
Net profit 2024
NOK 119K
-30% vs 2023
| Revenue | NOK 2M | +4% |
| EBITDA | NOK 152K | -30% |
| Net profit | NOK 119K | -30% |
| Total assets | NOK 548K | -7% |
| Equity | NOK 314K | +10% |
| Employees | 0 | — |
Legal name
FOKUS KLINIKK AS
Org number
914010969
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
15. august 2014
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Spesialisert senter for muskel og skjelett med tverrfaglig helseklinikk, fremleie av lokaler, kjøp og salg av helseprodukter og andre varer. Samt annen relevant virksomhet.
Address
Tørkoppveien 6, 1570 Dilling
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 870 | 1 752 | 1 817 | 1 897 | 1 969 |
| Staff expenses | −0 | −0 | −54 | −4 | −23 |
| EBITDA | 279 | 182 | 180 | 216 | 152 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 279 | 182 | 180 | 216 | 152 |
| Net financials | 0 | −0 | 0 | 0 | −0 |
| Profit before tax | 279 | 181 | 180 | 216 | 152 |
| Tax | 59 | 39 | 38 | 47 | 33 |
| Net profit | 219 | 143 | 142 | 169 | 119 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 623 | 535 | 529 | 589 | 548 |
| Equity | 266 | 289 | 296 | 285 | 314 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 356 | 246 | 233 | 304 | 234 |
| Total debt | 356 | 246 | 233 | 304 | 234 |
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
20202024
Equity ratio
57.4%
This company
38.2%
Market median
+50% vs market
20202024
Return on equity
37.9%
This company
18.4%
Market median
+106% vs market
20202024
Net profit margin
6.0%
This company
8.1%
Market median
-26% vs market
20202024
Asset turnover
3.59×
This company
1.12×
Market median
+221% vs market
20202024
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TB Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Former (1) | ||
| Chairman | 2019 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FOKUS KLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Trude Blomberg Andersen | Chief Executive Officer | 0 companies |
| Tom Ekerholt Skogtun | Chairman | 0 companies |
| Tom Skogtun | Chairman | 0 companies |
| Stian Karlsen | Board of Directors | 0 companies |